Paraplegia following intrathecal chemotherapy;PARAPLEGIE NACH INTRATHEKALER CHEMOTHERAPIE

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 25, 1996, Pages 1107-1111

  Beretta, F ^a   Sanna, P ^a   Ghielmini, M ^a   Marini, G ^a   Cavalli, F ^a  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; HYDROCORTISONE; METHOTREXATE; THIOTEPA;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LYMPHOBLASTOMA; MALE; PARAPLEGIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CISPLATIN; CYTARABINE; ETOPOSIDE; HUMANS; INJECTIONS, SPINAL; LYMPHOMA, LYMPHOBLASTIC; MALE; PARAPLEGIA; PREDNISONE;

EID: 0029990634     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gagliano RG, Costanzi JJ: Paraplegia following intrathecal methotrexate. Cancer 1976; 37: 1663-1668.
2. Gianni AM, Siena S, Bregni M: Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease. Ann Oncol 1991; 2: 645-653.
3. Wolff L, Zighelboim J, Gale RP: Paraplegia following intrathecal cytosine arabinoside. Cancer 1979; 43: 83-85.
4. Saiki JH, Thompson S, Smith F, Atkinson R: Paraplegia following intrathecal chemotherapy. Cancer 1972; 29: 370-374.
5. Breuer AC, Pitman SW, Dawson DM, Schoene WC: Paraparesis following intrathecal cytosine arabinoside. Cancer 1977; 40: 2817-2822.
6. Resar LMS, Phillips PC, Kastan MB, Leventhal BG, Bowman PW, Civin CI: Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type. Cancer 1993; 71: 117-123.
7. McLean DR, Clink HM, Ernst P, Coates R, Zuheir Al Kawi M et al.: Myelopathy after intrathecal chemotherapy. Cancer 1994; 73: 3037-3040.
8. Mena H, Garcia JH, Velandia F: Central and peripheral myelinopathy associated with systemic neoplasia and chemotherapy. Cancer 1981; 48: 1724-1737.
9. Gutin PH, Levi JA, Wiernik PH, Walker MD: Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study. Cancer Treat Rep 1977; 5: 885-887.
10. Clark AW, Cohen SR, Nissenblatt MJ, Wilson SK: Paraplegia following intrathecal chemotherapy. Cancer 1982; 50: 42-47.
11. Geiser CF, Bishop Y, Jaffe N: Adverse effects of intrathecal methotrexate in children with acute leukemia in remission. Blood 1975; 45: 189-195.
12. Asato R, Akiyama Y, Ito M, Kubota M, Okumura R et al.: Nuclear magnetic resonance abnormalities of cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 1992; 70: 1997-2004.
13. Price R, Jamieson P: The central nervous system in childhood leukemia: II. subacute leukoencephalopathy. Cancer 1975; 35: 306-318.
14. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS: Randomized prospective comparison of intraventicular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993; 11: 561-569
15. Gutin PH, Weiss HD, Wiernik PH, Walker MD: Intrathecal N,N′,N″-triethylenethiophosphoramide [thio-tepa (NSC 6396)] in the treatment of malignant meningeal disease, Phase I-II study. Cancer 1976; 38: 1471-1475.
16. Bleyer WA, Drake JC, Chabner BA: Neurotoxicity and elevated cerebrospinal fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973; 289: 770-773.
17. Pääkkö E, Vainionpää L, Lanning M, Laitinen J, Pyhtinen J: White matter changes in children treated for acute lymphoblastic leukemia. Cancer 1992; 70: 2728-2733.
18. Spiegel RJ, Cooper PR, Blum RH, Speyer JL, McBride D, Mangiardi J: Treatment of massive intrathecal methotrexate overdose by ventriculolumbar perfusion. N Engl J Med 1984; 311: 386-388.
19. Addiego JE, Ridgway D, Bleyer WA: The acute management of intrathecal methotrexate overdose: pharmacologic rationale and guidelines. J Pediatr 1981; 98: 825-828.
20. Ackland SP, Schilsky RL: High-dose methotrexate: a critical reappraisal. J Clin Oncol 1987; 5: 2017-2031.
21. Frick J, Ritch PS, Hansen RM, Anderson T: Successful treatment of meningeal leukemia using systemic high-dose cytosin arabinoside. J Clin Oncol 1984; 5: 365-368.
22. Morra E, Lazzarino M, Inverardi D, Brusamolino E, Orlandi E et al.: Systemic high-dose Ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma. J Clin Oncol 1986; 4: 1207-1211.